JP2023521037A5 - - Google Patents
Info
- Publication number
- JP2023521037A5 JP2023521037A5 JP2022560250A JP2022560250A JP2023521037A5 JP 2023521037 A5 JP2023521037 A5 JP 2023521037A5 JP 2022560250 A JP2022560250 A JP 2022560250A JP 2022560250 A JP2022560250 A JP 2022560250A JP 2023521037 A5 JP2023521037 A5 JP 2023521037A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- immune cells
- mitochondria
- modified
- human immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005167P | 2020-04-03 | 2020-04-03 | |
| US63/005,167 | 2020-04-03 | ||
| PCT/US2021/025643 WO2021203046A1 (en) | 2020-04-03 | 2021-04-02 | Enhancement of adoptive cell transfer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521037A JP2023521037A (ja) | 2023-05-23 |
| JP2023521037A5 true JP2023521037A5 (enExample) | 2024-04-15 |
Family
ID=75919371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560250A Pending JP2023521037A (ja) | 2020-04-03 | 2021-04-02 | 養子細胞移植の強化 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20210309967A1 (enExample) |
| EP (1) | EP4127141A1 (enExample) |
| JP (1) | JP2023521037A (enExample) |
| CN (1) | CN116096861A (enExample) |
| AU (1) | AU2021246112A1 (enExample) |
| CA (1) | CA3173391A1 (enExample) |
| WO (1) | WO2021203046A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12419913B2 (en) | 2019-02-08 | 2025-09-23 | Dna Twopointo, Inc. | Modification of CAR-T cells |
| EP4412627A1 (en) * | 2021-10-06 | 2024-08-14 | Cellvie Inc. | Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells |
| CN119365073A (zh) | 2022-06-10 | 2025-01-24 | 赛立维公司 | 用于冷冻保存线粒体的组合物和方法 |
| CN119816589A (zh) * | 2022-08-02 | 2025-04-11 | 国立大学法人北海道大学 | 使用细胞器复合体改善细胞疗法的方法 |
| AU2023356237A1 (en) * | 2022-10-06 | 2025-05-22 | Mitrix Bio Inc. | Formulations and methods for cellular therapies involving chimeric antigen receptors |
| WO2024097901A1 (en) * | 2022-11-02 | 2024-05-10 | Fate Therapeutics, Inc. | Off-the-shelf therapeutic cells with multiplex genomic engineering for targeting cd79b |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2832540C (en) | 2011-04-08 | 2020-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| CN106536056B (zh) | 2014-06-13 | 2021-07-16 | 儿童医学中心公司 | 分离线粒体的产品和方法 |
| WO2016008937A1 (en) * | 2014-07-16 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the intercellular transfer of isolated mitochondria in recipient cells |
| US20170333480A1 (en) * | 2014-11-05 | 2017-11-23 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| WO2017124037A1 (en) * | 2016-01-15 | 2017-07-20 | The Children's Medical Center Corporation | Therapeutic use of mitochondria and combined mitochondrial agents |
| KR101846464B1 (ko) * | 2016-11-14 | 2018-04-09 | 주식회사 파이안바이오테크놀로지 | 외래 미토콘드리아를 포함하는 자연살해세포 및 이를 포함하는 약학적 조성물 |
| EP3823646A4 (en) * | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of brain diseases |
| CN112543651B (zh) * | 2018-08-07 | 2023-06-02 | 普渡研究基金会 | 使car t细胞恢复活力 |
| US20200054682A1 (en) * | 2018-08-14 | 2020-02-20 | Imel Biotherapeutics, Inc. | Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy |
| BR112022019609A2 (pt) * | 2020-03-31 | 2022-11-29 | Minovia Therapeutics Ltd | Células geneticamente modificadas enriquecidas com mitocôndrias e usos das mesmas |
-
2021
- 2021-04-02 CN CN202180032504.XA patent/CN116096861A/zh active Pending
- 2021-04-02 AU AU2021246112A patent/AU2021246112A1/en active Pending
- 2021-04-02 CA CA3173391A patent/CA3173391A1/en active Pending
- 2021-04-02 EP EP21725850.8A patent/EP4127141A1/en active Pending
- 2021-04-02 WO PCT/US2021/025643 patent/WO2021203046A1/en not_active Ceased
- 2021-04-02 JP JP2022560250A patent/JP2023521037A/ja active Pending
- 2021-04-02 US US17/221,625 patent/US20210309967A1/en not_active Abandoned
-
2023
- 2023-07-21 US US18/356,949 patent/US20240052310A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023521037A5 (enExample) | ||
| JP6944497B2 (ja) | 新規に単離された細胞の治療組成物の操作および送達 | |
| US11123369B2 (en) | Bispecific CAR T-cells for solid tumor targeting | |
| JP7450892B2 (ja) | Ｎｋ細胞のための人工ｈｌａ陽性フィーダー細胞株及びその使用 | |
| CN107206024B (zh) | 改变cart细胞中的基因表达及其用途 | |
| ES2959443T3 (es) | Uso del dominio de señalización de CD2 en receptores de antígenos quiméricos de segunda generación | |
| JP7837068B2 (ja) | ユニバーサル抗原提示細胞およびその使用 | |
| JP2021121230A (ja) | キメラ抗原受容体（ｃａｒ）療法のためのｔ細胞の供給源としての骨髄浸潤リンパ球（ｍｉｌ） | |
| RS64420B1 (sr) | Pojačavanje efekta car-projektovanih t ćelija putem vakcinacije nukleinskom kiselinom | |
| WO2019052562A1 (zh) | Il-4r的融合蛋白及其应用 | |
| WO2022037562A1 (en) | Engineered immunoresponsive cells and uses thereof | |
| CN113396215A (zh) | 表达嵌合抗原受体(car)的骨髓浸润淋巴细胞(mil)、其制造方法及在疗法中使用的方法 | |
| Fenton et al. | Cellular cancer immunotherapy development and manufacturing in the clinic | |
| WO2021057906A1 (zh) | 表达il-15的免疫效应细胞 | |
| JP2024515815A (ja) | 組換え抗原提示細胞 | |
| US20240398950A1 (en) | Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells | |
| Nakanishi et al. | Synthetic mRNA for ex vivo therapeutic applications | |
| EP3991746A1 (en) | Transfection method | |
| CN118477171A (zh) | 脂质纳米颗粒 (lnp) 及其在细胞治疗中的用途 | |
| WO2023284875A1 (zh) | 嵌合抗原受体 | |
| US20240075085A1 (en) | Cancer therapy involving car-engineered t-cells and parvovirus h-1 | |
| HK40093010A (zh) | 涉及car工程化t细胞和细小病毒h-1的癌症疗法 | |
| WO2022218375A1 (zh) | 嵌合t细胞受体及其应用 | |
| EA051132B1 (ru) | Изменение экспрессии гена в cart-клетках и их применения |